Servier’s $1.55 billion muscular dystrophy drug fails major test
The French pharma Servier stated Tuesday that an experimental drug it bought in June for $1.55 billion in money, plus ...
Tag: Dystrophy
Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise Therapeutics
France-based pharma firm Servier is buying the muscular dystrophy enterprise of Edgewise Therapeutics as a part of a income progress ...
Sarepta to seek approval for gene therapy in rare muscular dystrophy
An experimental gene therapy from Sarepta Therapeutics increased levels of the gene missing in an ultra-rare form of muscular dystrophy, ...
Sarepta Stops Stop Shipments of Muscular Dystrophy Gene Therapy After Second Patient Death
A patient has died after receiving Sarepta Therapeutics’ approved gene therapy for Duchenne muscular dystrophy — the second fatality reported ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!